• Profile
Close

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: A pilot study

Clinical Ophthalmology Aug 11, 2017

Korol AR, et al. – The possible advantages of intravitreal aflibercept injections were examined for the treatment of choroidal neovascularization (CNV) secondary to chorioretinitis. It was inferred that intravitreal aflibercept had a positive clinical effect. It appeared to be well tolerated for the treatment of CNV linked with chorioretinitis. These data could aid in selecting the CNV treatment, secondary to chorioretinitis.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay